Til Sturmer
Overview
Explore the profile of Til Sturmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
297
Citations
7012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alson J, Orellana M, Robinson W, Williams P, Marsh E, Wood M, et al.
Am J Obstet Gynecol
. 2025 Mar;
PMID: 40086562
Background: Black people in the U.S. with endometrial cancer have a 5-year mortality rate that is more than twice that of white patients. This disparity is driven, in part, by...
2.
Frailty Trajectories Following Adjuvant Chemotherapy and Mortality in Older Women With Breast Cancer
Duchesneau E, Kim D, Sturmer T, Her Q, Zhang Z, Pajewski N, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250614.
PMID: 40072432
Importance: Frailty assessed at a single time point is associated with mortality in older women with breast cancer. Little is known about how changes in frailty following cancer treatment initiation...
3.
Wang T, Wang J, Song Z, Miller E, Pate V, Her Q, et al.
Am J Epidemiol
. 2025 Mar;
PMID: 40069957
Real-world evidence assessing dipeptidyl peptidase-4 inhibitors (DPP4i)'s risk of inflammatory bowel disease (IBD) is conflicting. One study modelling DPP4i as a time varying exposure (TVE) observed a harmful effect in...
4.
Soff S, Yoo Y, Bramante C, Reusch J, Huling J, Hall M, et al.
BMJ Open Diabetes Res Care
. 2025 Feb;
13(1).
PMID: 39904520
Introduction: Elevated glycosylated hemoglobin (HbA1c) in individuals with type 2 diabetes is associated with increased risk of hospitalization and death after acute COVID-19, however the effect of HbA1c on Long...
5.
6.
Duchesneau E, Sturmer T, Reeder-Hayes K, Kim D, Edwards J, Faurot K, et al.
Pharmacoepidemiol Drug Saf
. 2025 Jan;
34(2):e70103.
PMID: 39821599
Background: Frailty is an important prognostic indicator in older women with breast cancer. The Faurot frailty index, a validated claims-based frailty proxy measure, uses healthcare billing codes during a user-specified...
7.
Johnson S, Abedian S, Sturmer T, Huling J, Lewis V C, Buse J, et al.
Diabetes Care
. 2024 Sep;
47(11):1930-1940.
PMID: 39287394
Objective: Studies show metformin use before and during SARS-CoV-2 infection reduces severe COVID-19 and postacute sequelae of SARS-CoV-2 (PASC) in adults. Our objective was to describe the incidence of PASC...
8.
Wang T, Pate V, Wyss R, Buse J, Kosorok M, Sturmer T
Am J Epidemiol
. 2024 Sep;
PMID: 39245674
We recently developed a machine-learning subgrouping algorithm, iterative causal forest (iCF), to identify subgroups with heterogeneous treatment effects (HTEs) using predefined covariates. However, such predefined covariates may miss or poorly...
9.
Htoo P, Edwards J, Gokhale M, Pate V, Buse J, Jonsson-Funk M, et al.
Am J Epidemiol
. 2024 Sep;
PMID: 39223836
One obstacle to adopting instrumental variable (IV) methods in pharmacoepidemiology is their reliance on strong, unverifiable assumptions. We can falsify IV assumptions by leveraging the causal structure, which can strengthen...
10.
Latour C, Su I, Delgado M, Pate V, Poole C, Edwards J, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(9):e5885.
PMID: 39212064
Purpose: Although the limitations of hazard ratios (HRs) for quantifying treatment effects in right-censored data have been widely discussed, HRs are still preferentially reported over other, more interpretable effect measures....